In vitro response of monocyte-derived macrophages to a decellularized pericardial biomaterial

Journal of Biomedical Materials Research - Part A

Volumn 93, Issue 1, 2010, Pages 280-288

  Ariganello, Marianne B ^a   Labow, Rosalind S ^a,b,c   Lee, J Michael ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Acid phosphatase; Biomaterials; Collagen; Decellularized bovine pericardium; Macrophage

Indexed keywords

ACID PHOSPHATASE; BIOLOGICAL PERFORMANCE; BOVINE PERICARDIUM; CELL MODEL; CONTROL SURFACES; DECELLULARIZED; ESTERASE ACTIVITIES; EXTRACELLULAR; FOREIGN BODY RESPONSE; HEART VALVES; HUMAN MONOCYTE-DERIVED MACROPHAGES; HUMAN MONOCYTES; IN-VITRO; IN-VIVO; LAMELLIPODIA; MONOCYTE-DERIVED MACROPHAGES; NATIVE EXTRACELLULAR MATRIX; NOVEL METHODS; POLYDIMETHYLSILOXANE PDMS; RATIONAL DESIGN; TISSUE REGENERATION; TISSUE-CULTURE POLYSTYRENES;

ACIDS; BODY FLUIDS; CELL CULTURE; COLLAGEN; ENZYME ACTIVITY; MACROPHAGES; MICROCHANNELS; PHOSPHATASES; POLYSTYRENES; SCAFFOLDS; SILICONES; TISSUE; TISSUE CULTURE;

BIOMATERIALS;

ACID PHOSPHATASE; DIMETICONE; ESTERASE; POLYSTYRENE; TISSUE SCAFFOLD;

ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; COW; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FOREIGN BODY REACTION; HUMAN; HUMAN CELL; IMPLANTATION; LAMELLAR BODY; MACROPHAGE; MOLECULAR MODEL; MONOCYTE; MULTINUCLEAR CELL; NONHUMAN; PERICARDIUM; SURFACE PROPERTY; TISSUE CULTURE;

ACID PHOSPHATASE; ANIMALS; BIOCOMPATIBLE MATERIALS; CELLS, CULTURED; DNA; ESTERASES; HUMANS; IMMUNOBLOTTING; INTRACELLULAR SPACE; MACROPHAGES; MICROSCOPY, CONFOCAL; PERICARDIUM;

EID: 77649210987     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32554     Document Type: Article

References (34)

1. Schmidt D, Mol A, Kelm JM, Hoerstrup SP. In vitro heart valve tissue engineering. Methods Mol Med 2007;140:319-30.
2. Badylak SF. The extracellular matrix as a biologic scaffold material. Biomaterials 2007;28:3587-93.
3. Zilla P, Human P, Bezuidenhout D. Bioprosthetic heart valves: The need for a quantum leap. Biotechnol Appl Biochem 2004;40:57-66.
4. Schmidt D, Stock UA, Hoerstrup SP. Tissue engineering of heart valves using decellularized xenogeneic or polymeric starter matrices. Philos Trans R Soc Lond B Biol Sci 2007;362: 1505-1512.
5. Anderson J. Mechanisms of inflammation and infection with implanted devices. Cardiovasc Pathol 1993;2-3(Suppl):33S-41S.
6. Tsirogianni AK, Moutsopoulos NM, Moutsopoulos HM. Wound healing: Immunological aspects. Injury 2006;37(Suppl 1):S5-S12.
7. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 2008;13:453-461.
8. Riddle JM, Jennings JJ, Stein PD, Magilligan DJ Jr. A morphologic overview of the porcine bioprosthetic valve-before and after its degeneration. Scan Electron Microsc 1984(Pt 1):207-214.
9. Ray R, Choudhary SK, Kumar AS. Pathological aspects of explanted homograft mitral valve. Cardiovasc Pathol 2002;11: 177-180.
10. Lepidi H, Casalta JP, Fournier PE, Habib G, Collart F, Raoult D. Quantitative histological examination of bioprosthetic heart valves. Clin Infect Dis 2006;42:590-596.
11. Grabenwoger M, Fitzal F, Gross C, Hutschala D, Bock P, Brucke P, Wolner E. Different modes of degeneration in autologous and heterologous heart valve prostheses. J Heart Valve Dis 2000;9:104-109; discussion 110-111.
12. Dahm M, Husmann M, Eckhard M, Prufer D, Groh E, Oelert H. Relevance of immunologic reactions for tissue failure of bioprosthetic heart valves. Ann Thorac Surg 1995;60(2Suppl): S348-S352.
13. Nathan C. Points of control in inflammation. Nature 2002; 420:846-852.
14. Steed DL. Wound-healing trajectories. Surg Clin North Am 2003;83:547-55, vi-vii.
15. Rieder E, Seebacher G, Kasimir MT, Eichmair E, Winter B, Dekan B, Wolner E, Simon P, Weigel G. Tissue engineering of heart valves: Decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 2005;111:2792-2797.
16. Rieder E, Nigisch A, Dekan B, Kasimir MT, Muhlbacher F, Wolner E, Simon P, Weigel G. Granulocyte-based immune response against decellularized or glutaraldehyde crosslinked vascular tissue. Biomaterials 2006;27:5634-5642.
17. Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, Rieder E, Wolner E. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 2003;23:1002-1006; discussion 1006.
18. Ariganello MB, Labow RS, Lee JM. Response of macrophagelike U937 cells to decellularized tissue heart valve materials. J Heart Valve Dis 2009;18:187-197.
19. Courtman DW, Pereira CA, Kashef V, McComb D, Lee JM, Wilson GJ. Development of a pericardial acellular matrix biomaterial: Biochemical and mechanical effects of cell extraction. J Biomed Mater Res 1994;28:655-666.
20. Labow RS, Meek E, Santerre JP. Model systems to assess the destructive potential of human neutrophils and monocytederived macrophages during the acute and chronic phases of inflammation. J Biomed Mater Res 2001;54:189-197.
21. Matheson LA, Santerre JP, Labow RS. Changes in macrophage function and morphology due to biomedical polyurethane surfaces undergoing biodegradation. J Cell Physiol 2004;199:8-19.
22. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
23. Matheson LA, Maksym GN, Santerre JP, Labow RS. Cyclic biaxial strain affects U937 macrophage-like morphology and enzymatic activities. J Biomed Mater Res A 2006;76:52-62.
24. Labow RS, Meek E, Matheson LA, Santerre JP. Human macrophage-mediated biodegradation of polyurethanes: Assessment of candidate enzyme activities. Biomaterials 2002;23: 3969-3975.
25. Uphoff CC, Drexler HG. Biology of monocyte-specific esterase. Leuk Lymphoma 2000;39:257-270.
26. Bune AJ, Hayman AR, Evans MJ, Cox TM. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disordered macrophage inflammatory responses and reduced clearance of the pathogen, Staphylococcus aureus. Immunology 2001;102:103-113.
27. DeFife KM, Jenney CR, Colton E, Anderson JM. Cytoskeletal and adhesive structural polarizations accompany IL-13-induced human macrophage fusion. J Histochem Cytochem 1999;47:65-74.
28. Linder S. The matrix corroded: Podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol 2007;17: 107-117.
29. Ziegler WH, Liddington RC, Critchley DR. The structure and regulation of vinculin. Trends Cell Biol 2006;16:453-460.
30. Matthews JB, Green TR, Stone MH, Wroblewski BM, Fisher J, Ingham E. Comparison of the response of three human monocytic cell lines to challenge with polyethylene particles of known size and dose. J Mater Sci Mater Med 2001;12:249-258.
31. Harris P, Ralph P. Human leukemic models of myelomonocytic development: A review of the HL-60 and U937 cell lines. J Leukoc Biol 1985;37:407-422.
32. Gowen BB, Borg TK, Ghaffar A, Mayer EP. Selective adhesion of macrophages to denatured forms of type I collagen is mediated by scavenger receptors. Matrix Biol 2000;19:61-71.
33. Duffield JS. The inflammatory macrophage: A story of Jekyll and Hyde. Clin Sci (Lond) 2003;104:27-38.
34. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005;5:953-964.